OmniSonics secures $26 million to further develop OmniWave:
This article was originally published in Clinica
Executive Summary
OmniSonics has raised $26m through third round financing to further develop its OmniWave technology platform. OmniWave, a technology that enables the delivery of acoustic energy over the active length of a small diameter wire in an occluded blood vessel, became available on the European market earlier this year and the Wilmington, Massachusetts-based company now has its sights set on the US. The technology's pre-clinical coronary data were presented at last month's Transcatheter Cardiovascular Therapeutics (TCT) meeting and the company's confidence in OmniWave's future is strong. President and CEO Robert Rabiner said that raising the finance "speaks to the promise" of the technology, and is looking forward to "advancing the product within multiple areas of the cardiovascular field". The financing is being led by new investor General Electric Pension Trust.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.